Net Change in Cash
Eli Lilly Net Change in Cash decreased by 131.0% to -$1.99B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1034.2%, from -$175.10M to -$1.99B. Over 2 years (FY 2021 to FY 2023), Net Change in Cash shows an upward trend with a 115.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
Detailed definition
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
Peer comparison
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
net_change_in_cashHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $217.60M | $568.20M | $30.30M | -$1.36B | $163.70M | -$5.50M | -$550.40M | $1.48B | -$851.40M | -$313.70M | $437.80M | -$358.40M | $763.40M | $145.40M | -$175.10M | $282.60M | $6.42B | -$1.99B |
| QoQ Change | — | +161.1% | -94.7% | <-999% | +112.0% | -103.4% | <-999% | +368.7% | -157.6% | +63.2% | +239.6% | -181.9% | +313.0% | -81.0% | -220.4% | +261.4% | >999% | -131.0% |
| YoY Change | — | — | — | — | -24.8% | -101.0% | <-999% | +208.8% | -620.1% | <-999% | +179.5% | -124.2% | +189.7% | +146.4% | +51.1% | -63.0% | >999% | <-999% |
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Eli Lilly's net change in cash?
- Eli Lilly (LLY) reported net change in cash of -$1.99B in Q1 2026.
- How has Eli Lilly's net change in cash changed year-over-year?
- Eli Lilly's net change in cash decreased by 1034.2% year-over-year, from -$175.10M to -$1.99B.
- What is the long-term trend for Eli Lilly's net change in cash?
- Over 2 years (2021 to 2023), Eli Lilly's net change in cash has grown at a 115.8% compound annual growth rate (CAGR), from $161.40M to $751.60M.
- What does net change in cash mean?
- The total change in the company's cash balance after accounting for all spending, earning, and investment activities.